Literature DB >> 9848808

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.

R O'Hara1, J A Yesavage, H C Kraemer, M Mauricio, L F Friedman, G M Murphy.   

Abstract

OBJECTIVE: This study investigated whether the Apolipoprotein (APOE) epsilon4 allele was associated with cognitive decline in community-dwelling older adults.
DESIGN: Longitudinal cognitive performance of older adults with the epsilon3/epsilon4 genotype was compared with that of older adults with the epsilon3/epsilon3 genotype.
SETTING: Aging Clinical Research Center, Stanford University. PARTICIPANTS: One hundred community-dwelling older adults were recruited from a pool of 531 individuals who had participated in a memory training study 4 to 5 years earlier. These individuals were concerned about their memory functioning and were recruited through newspaper advertisements and contacts with local senior centers. The 100 individuals who agreed to participate in the follow-up investigation were between 59 and 95 years of age. MEASUREMENTS: At both baseline and follow-up, subjects were administered a battery of seven cognitive tests that examined verbal and spatial memory, attention, speed-of-processing, and language abilities. APOE genotype was determined at follow-up.
RESULTS: Individuals with the epsilon3/epsilon4 APOE genotype were significantly younger than individuals with the APOE epsilon3/epsilon3 genotype. No significant differences were observed between the two groups on measures of attention, speed-of-processing, vocabulary, immediate verbal memory, and immediate spatial memory. However, those older adults with the epsilon3/epsilon4 genotype exhibited significantly greater decline in performance on delayed recall of verbal material than did those with the epsilon3/epsilon3 APOE genotype.
CONCLUSION: These findings are consistent with previous studies, which suggest that the APOE epsilon4 allele predicts decline on measures of delayed recall.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848808     DOI: 10.1111/j.1532-5415.1998.tb01532.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  33 in total

1.  Update on Alzheimer's disease: recent findings and treatments.

Authors:  R O'Hara; M S Mumenthaler; J A Yesavage
Journal:  West J Med       Date:  2000-02

2.  Acute responses to estradiol replacement in the olfactory system of apoE-deficient and wild-type mice.

Authors:  Britto P Nathan; Michael Tonsor; Robert G Struble
Journal:  Brain Res       Date:  2010-05-04       Impact factor: 3.252

Review 3.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

Authors:  Susan De Santi; Elizabeth Pirraglia; William Barr; James Babb; Schantel Williams; Kimberley Rogers; Lidia Glodzik; Miroslaw Brys; Lisa Mosconi; Barry Reisberg; Steven Ferris; Mony J de Leon
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

5.  Regional brain activation during verbal declarative memory in metastatic breast cancer.

Authors:  Shelli R Kesler; F Chris Bennett; Misty L Mahaffey; David Spiegel
Journal:  Clin Cancer Res       Date:  2009-10-20       Impact factor: 12.531

6.  Association between subjective memory assessment and associative memory performance: Role of ad risk factors.

Authors:  Marci M Horn; Kristen M Kennedy; Karen M Rodrigue
Journal:  Psychol Aging       Date:  2018-02

7.  COMT genotype, gender and cognition in community-dwelling, older adults.

Authors:  Ruth O'Hara; Elana Miller; Chun-Ping Liao; Nate Way; Xiaoyan Lin; Joachim Hallmayer
Journal:  Neurosci Lett       Date:  2006-10-09       Impact factor: 3.046

8.  The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge.

Authors:  Nunzio Pomara; Kenneth D Belzer; Raul Silva; Thomas B Cooper; John J Sidtis
Journal:  Psychopharmacology (Berl)       Date:  2008-07-31       Impact factor: 4.530

9.  Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.

Authors:  G A Dore; M F Elias; M A Robbins; P K Elias; Z Nagy
Journal:  Diabetologia       Date:  2009-08-20       Impact factor: 10.122

10.  Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb.

Authors:  Ikemefuna Nwosu; Salina Gairhe; Robert G Struble; Britto P Nathan
Journal:  Neurosci Lett       Date:  2008-06-11       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.